Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Metabolite-P450 complex formation by methylenedioxyphenyl HIV protease inhibitors in rat and human liver microsomes.

Chiba M, Nishime JA, Chen IW, Vastag KJ, Sahly YS, Kim BM, Dorsey BD, Vacca JP, Lin JH.

Biochem Pharmacol. 1998 Jul 15;56(2):223-30.

PMID:
9698076
2.

Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.

Lin JH, Chiba M, Chen IW, Nishime JA, Vastag KJ.

Drug Metab Dispos. 1996 Dec;24(12):1298-306.

PMID:
8971134
3.

Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.

Lin JH, Chiba M, Balani SK, Chen IW, Kwei GY, Vastag KJ, Nishime JA.

Drug Metab Dispos. 1996 Oct;24(10):1111-20.

PMID:
8894513
4.
5.

Time- and dose-dependent pharmacokinetics of L-754,394, an HIV protease inhibitor, in rats, dogs and monkeys.

Lin JH, Chiba M, Chen IW, Vastag KJ, Nishime JA, Dorsey BD, Michelson SR, McDaniel SL.

J Pharmacol Exp Ther. 1995 Jul;274(1):264-9.

PMID:
7616407
6.

pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs.

Lin JH, Chen IW, Vastag KJ, Ostovic D.

Drug Metab Dispos. 1995 Jul;23(7):730-5.

PMID:
7587962

Supplemental Content

Loading ...
Support Center